###begin article-title 0
A Large Scale shRNA Barcode Screen Identifies the Circadian Clock Component ARNTL as Putative Regulator of the p53 Tumor Suppressor Pathway
###end article-title 0
###begin p 1
Conceived and designed the experiments: JM AWF RB RB. Performed the experiments: JM AWF MM. Analyzed the data: JM AWF RB. Wrote the paper: JM AWF RB RB. Performed the microarray hybridizations: MM. Supervised the research and corrected the manuscript: RB RLB.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 58 63 <span type="species:ncbi:9606">human</span>
The p53 tumor suppressor gene is mutated in about half of human cancers, but the p53 pathway is thought to be functionally inactivated in the vast majority of cancer. Understanding how tumor cells can become insensitive to p53 activation is therefore of major importance. Using an RNAi-based genetic screen, we have identified three novel genes that regulate p53 function.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 414 419 414 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 421 426 421 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBCK1</italic>
###xml 431 436 431 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNIP1</italic>
###xml 496 501 496 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 503 508 503 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BMAL1</italic>
###xml 716 721 716 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 827 831 827 831 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 824 831 824 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>CIP1</sup></italic>
###xml 55 60 <span type="species:ncbi:9606">human</span>
We have screened the NKI shRNA library targeting 8,000 human genes to identify modulators of p53 function. Using the shRNA barcode technique we were able to quickly identify active shRNA vectors from a complex mixture. Validation of the screening results indicates that the shRNA barcode technique can reliable identify active shRNA vectors from a complex pool. Using this approach we have identified three genes, ARNTL, RBCK1 and TNIP1, previously unknown to regulate p53 function. Importantly, ARNTL (BMAL1) is an established component of the circadian regulatory network. The latter finding adds to recent observations that link circadian rhythm to the cell cycle and cancer. We show that cells having suppressed ARNTL are unable to arrest upon p53 activation associated with an inability to activate the p53 target gene p21CIP1.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
We identified three new regulators of the p53 pathway through a functional genetic screen. The identification of the circadian core component ARNTL strengthens the link between circadian rhythm and cancer.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 89 92 89 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Vousden1">[1]</xref>
###xml 94 97 94 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Toledo1">[2]</xref>
###xml 402 405 402 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Chuikov1">[3]</xref>
###xml 422 425 422 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Brooks1">[4]</xref>
###xml 427 430 427 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Brooks2">[5]</xref>
###xml 447 450 447 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Gu1">[6]</xref>
###xml 598 601 598 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 614 617 614 617 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 671 674 671 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Momand1">[7]</xref>
###xml 865 868 865 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Riley1">[8]</xref>
The TP53 gene product is important in the cellular response to different types of stress [1], [2]. A major physiological stress is DNA damage. DNA damage leads to activation of the ATM/ATR, CHK1/2 cascade, which in turn activates p53. Activation of p53 is achieved by increased stability and post translational modifications of the p53 protein. These modifications include phosphorylation, methylation [3], ubiquitination [4], [5] and acetylation [6] leading to enhanced transcriptional activity of p53. Furthermore, oncogene activation can also lead to p53 activation through activation of the p19ARF protein. p19ARF inhibits MDM2, the major E3 ubiquitin ligase for p53 [7] leading to stabilization and activation of p53. Activation of p53 leads to transcriptional activation of a large set of p53 target genes, which in turn causes cell cycle arrest or apoptosis [8].
###end p 9
###begin p 10
###xml 59 62 59 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-httpwwwp53.iarc.fr1">[9]</xref>
###xml 138 142 138 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 375 379 375 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDM2</italic>
###xml 438 441 438 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Toledo1">[2]</xref>
###xml 443 447 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Oliner1">[10]</xref>
###xml 45 50 <span type="species:ncbi:9606">human</span>
###xml 81 86 <span type="species:ncbi:9606">human</span>
###xml 193 198 <span type="species:ncbi:9606">human</span>
The p53 pathway is inactivated in almost all human cancers [9]. In about half of human cancers this is due to mutation or deletion of the TP53 gene itself. However in a significant fraction of human tumors, the p53 pathway is inactivated through alteration in cellular components acting up- or down-stream of p53. For example, amplification of the negative regulator of p53, MDM2, leads to accelerated degradation and inactivation of p53 [2], [10].
###end p 10
###begin p 11
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Berns1">[11]</xref>
###xml 85 90 <span type="species:ncbi:9606">human</span>
###xml 189 193 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
As a model to screen for genes that modulate p53 function, we previously developed a human fibroblast cell line named BJtsLT [11]. These cells express a temperature-sensitive mutant of the SV40 large T antigen, which allows the cells to proliferate at the permissive temperature (32degreesC). However, when the cells are shifted to 39degreesC, the large T antigen is degraded and the cells enter a stable p53-dependent cell cycle arrest.
###end p 11
###begin p 12
###xml 126 130 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Berns1">[11]</xref>
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Schlabach1">[17]</xref>
We and others have previously described the construction and initial screening of shRNA libraries using the barcode technique [11]-[17]. The barcode technique allows the rapid identification of individual shRNA vectors from a large pool of shRNA vectors that produce a specific phenotype. This approach takes advantage of the fact that each shRNA vector contains a unique 19-mer sequence as part of the shRNA cassette, which can serve as a molecular "barcode" identifier. Briefly, cells are infected with the pooled shRNA library of some 24,000 vectors. The population of cells is then split into two separate populations. One population is used as a reference sample while the other sample is subjected to a selective treatment. Knockdown of a specific gene by the shRNA vector can lead to three possible cellular responses to this treatment. First the cells can remain unaffected identical to control cells, second the cells can become more sensitive to the treatment and third the cells can acquire resistance to the treatment. As a consequence of the differential response to the treatment, the relative number of cells that harbor a specific shRNA can increase, decrease or remain the same. The relative abundance of each shRNA cassette can be determined by the isolation of the shRNA cassettes from the population, labeling of the barcode identifiers with different fluorescent dyes and subsequent hybridization to DNA microarrays representing all shRNA sequences. By comparing the relative abundance of all shRNAs against the reference population, shRNAs responsible for the three possible phenotypes can be identified.
###end p 12
###begin p 13
###xml 357 361 357 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Brummelkamp1">[13]</xref>
###xml 523 527 523 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 622 626 622 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Berns2">[12]</xref>
###xml 813 821 813 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
The shRNA barcode technique can be used for different screening approaches, most notably the identification of genes that are involved in drug resistance. For instance, we have used the barcoding approach to identify genes that are involved in the resistance to the cytotoxic effects of Nutlin-3, a drug that activates p53 by acting as an inhibitor of MDM2 [13]. This led to the identification of 53BP1, a p53 binding protein, as a critical modulator of the effect of Nutlin-3. More recently, we found the tumor suppressor PTEN as a gene, which upon decreased expression confers resistance to trastuzumab in breast cancer [12]. Significantly, the PI3K pathway, which is negatively regulated by PTEN, was also shown to be a major regulator of trastuzumab sensitivity in the clinic, underscoring the utility of the in vitro genetic screens to identify drug modulators.
###end p 13
###begin p 14
###xml 128 132 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Berns1">[11]</xref>
In the first screen applying the NKI shRNA library, Berns et al. used BJtsLT cells to identify 5 new players in the p53 pathway [11]. This screen did not take advantage of the barcode technology. Rather, it was performed by the conventional method of isolating and expanding colonies that are resistant to p53-mediated growth arrest. Subsequent isolation of the shRNA inserts and sequence analysis was required to identify the shRNA responsible for the bypass of the p53 mediated cell cycle arrest. This method is rather laborious and such an approach may not uncover all active shRNAs in a library. Moreover, due to the labour-intensive nature of the screen, only part of the 24,000 vector NKI shRNA library was covered in this initial approach. Here we describe the screening of the entire NKI shRNA library for modulators of p53 activity using the barcode technology. We find three additional genes whose suppression causes resistance to p53-dependent proliferation arrest.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
Screening of the BJtsLT cells
###end title 16
###begin p 17
###xml 171 180 171 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004798-g001">Figure 1a</xref>
###xml 287 291 275 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Berns1">[11]</xref>
###xml 2158 2167 2092 2101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004798-g001">figure 1b</xref>
To identify shRNA vectors that can modulate the activity of the p53 pathway, we performed a shRNA bar code screen in BJtsLT cells infected with the NKI shRNA library (See Figure 1a). These cells proliferate at 32degreesC but enter into a p53-dependent proliferation arrest at 39degreesC [11]. The infected cells were cultured for three days at 32degreesC to allow retroviral integration and for gene knockdown to become effective. At day 4 the cells were split into two populations; one was kept at 32degreesC and the other was shifted to 39degreesC. The BJtsLT at 32degreesC were cultured until the population reached confluency and genomic DNA was isolated. The BJtsLT cells grown at 39degreesC cease proliferation unless a shRNA is expressed that inactivates the p53-dependent anti-proliferative response. Such cells will continue to proliferate and give rise to a colony. In addition to infection with the NKI shRNA library, we also used a shRNA vector targeting p53 as a positive control for colony outgrowth of the BJtsLT cells at 39degreesC. After 3 weeks of culturing at 39degreesC, the control plates infected with p53 shRNA vector contained large numbers of colonies consisting of rapidly proliferating cells (data not shown). The plates infected with the shRNA library also contained several colonies. Colonies from the library-infected plates were pooled and genomic DNA was isolated. The shRNA cassettes were recovered from the genomic DNA using PCR. The recovered shRNA inserts from both the control population and the colonies that continued proliferation at 39degreesC following infection with the shRNA library, were used to hybridize DNA microarrays containing all 24,000 19-mer sequences of the NKI shRNA library. The hybridization was performed for each of the replicate experiments, after which the results were combined to increase the statistical significance of the enriched shRNA vectors identified. Those shRNA vectors that confer resistance to the p53 mediated cell cycle arrest are enriched in the population cultured at 39degreesC and can be detected as outliers in a MA-plot representation of the barcode microarray experiment (figure 1b).
###end p 17
###begin title 18
shRNA barcode screen identifies mediators of the p53 dependent cell cycle arrest.
###end title 18
###begin p 19
###xml 470 471 446 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 477 478 453 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 506 507 482 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 509 510 485 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
a) Schematic outline of the BJtsLT genetic screen. BJtsLT cells were infected with the NKI shRNA library and were either left at 32degreesC or shifted to 39degreesC. After 7 days the cells at 32degreesC had reached confluency and were harvested. Cells at 39degreesC were harvested after 23 days after which they had formed visible colonies. b) Analysis of the relative abundance of shRNAs recovered from the BJtsLT barcode experiment. Data are normalized and plotted as M, the 2log (ratio Cy5/Cy3), versus A (2log(radicalintensity Cy3xCy5)). The data are the average of two independent hybridization experiments performed in duplicate with reversed colour. A red box is drawn around the top 100 enriched shRNAs at 39degreesC. c) Schematic overview of selection criteria used to select hits from the shRNA barcode screen for further validation.
###end p 19
###begin p 20
###xml 203 212 197 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004798-g001">figure 1c</xref>
From this MA-plot we generated a "hit list" of shRNA vectors that are specifically enriched in cell cultured at 39degreesC. The following considerations were used to produce this hit list (summarized in figure 1c). We excluded all shRNAs that had an intensity (A-value) lower than 10, as spots with a relative low intensity are likely to be "noise" and as a consequence can have aberrantly high "M" ratios. In addition we only included shRNAs if their ratio (M = 2log ratio cy5/cy3) was >0.75, this effectively means the top 100 most enriched shRNAs on the micro-array.
###end p 20
###begin p 21
###xml 309 316 309 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004798-t001">Table 1</xref>
###xml 396 400 396 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cip1</sup>
###xml 516 520 516 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cip1</sup>
###xml 789 794 789 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HDAC4</italic>
###xml 800 807 800 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KIA0828</italic>
###xml 815 821 815 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTATIP</italic>
To shorten the list of shRNA vectors to be validated, we first asked where shRNA vectors targeting known components of the p53 pathway were positioned in the top 100. In total, five shRNA vectors targeting known components of the p53 pathway were present in the top 100 and their distribution was as follows (Table 1): one shRNA vector targeting p53 (position #8), two shRNA vectors targeting p21cip1 (#7 & #37) and two shRNA vectors targeting 53BP1 (#5 & #36). As we identified shRNA vectors targeting 53BP1 and p21cip1 at positions 36 and 37 on the hit list, we decided to individually test all shRNA vectors on positions 1-37 in a second round selection. Included in this set are vectors targeting 3 out of 5 genes that were previously identified and validated by Berns et al., (2004): HDAC4 (#2) KIA0828 (#13), HTATIP (#25). The identification of these shRNA vectors provides further support for the notion that the barcode method enables both fast and reliable screening of shRNA libraries.
###end p 21
###begin title 22
###xml 63 72 63 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004798-g001">figure 1c</xref>
List of shRNA vectors that were selected by the criteria as in figure 1c. Depicted are shRNAs that were used in validation experiments.
###end title 22
###begin p 23
###xml 64 65 64 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 80 81 80 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 108 109 108 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Under rescue; + means a validated shRNA, - means not validated. M indicates the 2log (ratio Cy5/Cy3), A the 2log(radicalintensity Cy3xCy5).
###end p 23
###begin p 24
###xml 626 630 626 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Birmingham1">[18]</xref>
###xml 632 636 632 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Echeverri1">[19]</xref>
###xml 661 667 661 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL </italic>
###xml 668 670 668 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</italic>
###xml 667 671 667 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Bunger1">[<italic>20</italic>]</xref>
###xml 673 679 673 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBCK1 </italic>
###xml 680 682 680 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">21</italic>
###xml 679 683 679 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Yamanaka1">[<italic>21</italic>]</xref>
###xml 688 694 688 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNIP1 </italic>
###xml 695 697 695 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">22</italic>
###xml 694 698 694 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Heyninck1">[<italic>22</italic>]</xref>
In addition, we selected 3 genes that were represented by two independent shRNAs in the top 100 (of which one is present in the 37 already selected shRNAs), bringing the total number of shRNAs to be tested to 42. We included these 3 additional genes in the validation, because if two independent shRNAs targeting the same transcript are enriched in the shRNA screen, this gives higher level of confidence to that specific hit. This is because it is less likely to be "off target" when two independent shRNAs yield the same phenotype and such off target effects of shRNAs are a common problem in these types of genetic screens [18], [19]. The other three genes, ARNTL [20], RBCK1 [21] and TNIP1 [22] have not been linked to p53 before.
###end p 24
###begin p 25
###xml 845 850 827 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 852 869 834 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBCK1 and TNIP1 (</italic>
###xml 869 877 851 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2</italic>
###xml 869 877 851 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004798-g002"><italic>Figure 2</italic></xref>
###xml 877 878 859 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</italic>
To prove that the shRNA barcode technique specifically identifies shRNAs that are enriched in the experiment we also tested 30 randomly-selected shRNAs not enriched in the experiment. All shRNAs were re-tested in the BJtsLT cells. Cells were infected with individual shRNAs, shifted to 39degreesC and incubated for 3 weeks. When colonies were observed the cells were fixed and stained. As expected, none of the 30 randomly-selected shRNAs was able to produce colonies at 39degreesC (data not shown). However, for 37 of the 42 enriched shRNA vectors, we could clearly demonstrate that they allowed the cells to proliferate at 39degreesC. Among the genes targeted by these 37 shRNA vectors were all known p53 pathway components. In addition, we also observed rescue of growth arrest by all three genes that were targeted by two individual shRNAs: ARNTL, RBCK1 and TNIP1 (Figure 2). Therefore we decided to focus on these three newly identified genes for which we identified two independent shRNAs.
###end p 25
###begin title 26
Colony formation ARNTL, RBCK1 and TNIP1 shRNA vectors.
###end title 26
###begin p 27
Cells were infected with shRNA vectors targeting ARNTL, RBCK1 and TNIP1 and control shRNA vectors targeting GFP, p53, 53BP1 and p21. Cells were infected at 32degreesC and shifted to 39degreesC 2 days after infection. After three weeks culture at 39degreesC, the cells were fixed and stained.
###end p 27
###begin p 28
###xml 125 130 125 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 132 137 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBCK1</italic>
###xml 142 147 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNIP1</italic>
###xml 494 502 494 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004798-g002">Figure 2</xref>
To show the sensitivity and selectivity of the shRNA barcode technique, we decided to test all three shRNA vectors targeting ARNTL, RBCK1 and TNIP1 that are present in the library. As mentioned before, for these three genes we found only two of the three shRNAs to be enriched in the screen, whereas one shRNA vector was not enriched. When we infected all three shRNA vectors independently into BJtsLT cells we found that only shRNAs enriched in the shRNA barcode screen gave rise to colonies (Figure 2).
###end p 28
###begin title 29
Knockdown of target genes by shRNA vectors
###end title 29
###begin p 30
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNIP1</italic>
###xml 70 75 70 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBCK1</italic>
###xml 494 511 482 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004798-g003">Figure 3a, 3b, 3c</xref>
###xml 944 953 932 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004798-g003">Figure 3d</xref>
###xml 1046 1055 1034 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004798-g003">Figure 3e</xref>
Next, we investigated if the shRNA vectors targeting ARNTL, TNIP1 and RBCK1 also reduced mRNA levels of their cognate target genes. BJtsLT cells were infected at 32degreesC and shifted to 39degreesC 3 days after infection. When colonies appeared, RNA was isolated and subjected to quantification by QRT-PCR. The result from the QRT-PCR showed that enriched shRNA vectors targeting ARNTL, RBCK1 and TNIP1 were more potent in decreasing target mRNA than the shRNA vectors that were not enriched (Figure 3a, 3b, 3c). In addition, we tested for both ARNTL and TNIP1 if protein levels were also affected by the shRNA vectors. For ARNTL we co-expressed the three shRNA vectors together with a cDNA encoding hARNTL in Phoenix cells. From the western blot analysis it was clear that only the vectors that could produce colonies also induced potent knockdown of protein expression, thus linking gene knockdown to the p53 growth arrest bypass phenotype (Figure 3d). Knockdown of TNIP1 was determined by analyzing endogenous protein levels in BJtsLT cells (Figure 3e). As can be seen only the vectors that are enriched in the barcode screen and validated to enable colony growth at 39degreesC were able to reduce endogenous TNIP1 protein levels. We conclude that by limiting the hit selection to genes that are targeted by two independent shRNAs we have only selected 'on-target' hits from a complex library.
###end p 30
###begin title 31
Barcode identified shRNA vectors suppress protein and mRNA levels of their targets.
###end title 31
###begin p 32
a) QRT-PCR for ARNTL in BJtsLT cells. BJtsLT cells were infected with indicated shRNA vectors. Samples for RNA isolation were taken 8 days after shift to 39degreesC. b) QRT-PCR for RBCK1 in BJtsLT cells. BJtsLT cells were infected with indicated shRNA vectors. Samples for RNA isolation were taken 8 days after shift to 39degreesC. c) QRT-PCR for TNIP1 in BJtsLT cells. BJtsLT cells were infected with indicated shRNA vectors. Samples for RNA isolation were taken 8 days after shift to 39degreesC. d) Flag-ARNTL together with the shRNA vectors targeting ARNTL were transiently transfected in Phoenix cells. Extracts were immunoblotted using Flag and CDK4 (control) antibodies. e) BJ cells were infected with the indicated shRNA vectors and Extracts were immunoblotted using TNIP1 and CDK4 (control) antibodies.
###end p 32
###begin title 33
###xml 72 76 72 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
Knockdown of ARNTL, RBCK1 and TNIP1 in BJtsLT cells leads to reduced p21CIP1 levels
###end title 33
###begin p 34
###xml 3 7 3 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>CIP1</sup></italic>
###xml 78 82 78 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-elDeiry1">[23]</xref>
###xml 159 163 159 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 156 163 156 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>CIP1</sup></italic>
###xml 259 264 259 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 266 271 266 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBCK1</italic>
###xml 276 281 276 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNIP1</italic>
###xml 288 292 288 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 285 292 285 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>CIP1</sup></italic>
###xml 332 336 332 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 463 467 457 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 496 505 490 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004798-g004">Figure 4a</xref>
###xml 529 533 523 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 605 608 599 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 613 617 607 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 610 617 604 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>CIP1</sup></italic>
###xml 621 626 615 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">53BP1</italic>
###xml 628 637 622 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004798-g004">Figure 4a</xref>
###xml 677 682 671 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 684 689 678 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBCK1</italic>
###xml 694 699 688 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNIP1</italic>
###xml 729 733 723 727 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 862 873 850 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004798-g004">Figure 4a&#8211;c</xref>
p21CIP1 is one of the critical effectors of p53 to induce a cell cycle arrest [23]. This is further supported by our identification of two shRNAs targeting p21CIP1 in the list of outliers of the BJtsLT screen. We therefore examined the effect of knockdown of ARNTL, RBCK1 and TNIP1 on p21CIP1 induction. We tested the effects on p21CIP1 in the BJtsLT system that we used for the initial screen. When BJtsLT cells are shifted to 39degreesC, a rapid increase in p21CIP1 protein levels is observed (Figure 4a). As expected, this p21CIP1 induction is attenuated in cells infected with shRNA vectors targeting p53, p21CIP1 or 53BP1 (Figure 4a). When we used shRNA vectors targeting ARNTL, RBCK1 and TNIP1 we observed a decrease in p21CIP1 levels for those shRNA vectors that produced colonies at 39degreesC, but not for shRNA vectors that failed to produce colonies (Figure 4a-c).
###end p 34
###begin title 35
###xml 48 52 48 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
Knockdown of ARNTL, TNIP1 and RBCK1 prevents p21CIP1induction in BJtsLT cells.
###end title 35
###begin p 36
###xml 243 247 225 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 249 260 231 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004798-g004">Figure 4a&#8211;c</xref>
###xml 328 332 310 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 334 343 316 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004798-g004">Figure 4d</xref>
BJtsLT cells were infected at 32degreesC and shifted to 39degreesC for colony formation. After 14 days of culturing at 39degreesC cells were harvested, protein lysates were prepared and subjected to western blot for p53, CDK4 (control) and p21CIP1 (Figure 4a-c). Additionally, total RNA was isolated and used for QRT-PCR for p21CIP1 (Figure 4d).
###end p 36
###begin p 37
###xml 35 39 35 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 83 87 83 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 80 87 80 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>CIP1</sup></italic>
###xml 121 125 121 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 118 125 118 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>CIP1</sup></italic>
###xml 150 159 150 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004798-g004">Figure 4d</xref>
###xml 244 248 238 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 241 248 235 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>CIP1</sup></italic>
###xml 298 303 292 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 305 310 299 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBCK1</italic>
###xml 315 320 309 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNIP1</italic>
###xml 396 400 390 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 393 400 387 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>CIP1</sup></italic>
To be sure that the decrease in p21CIP1 protein levels were caused by decreased p21CIP1transcription we also measured p21CIP1 mRNA levels by QRT-PCR (Figure 4d). All shRNAs that could produce colonies at 39degreesC also showed a decrease in p21CIP1 mRNA. This result suggests that the knockdown of ARNTL, RBCK1 and TNIP1 leads to a decreased transcriptional activity of p53 towards its target p21CIP1.
###end p 37
###begin p 38
###xml 94 98 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Fu1">[24]</xref>
###xml 99 103 99 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Gery1">[26]</xref>
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Bunger1">[20]</xref>
###xml 183 187 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Panda1">[27]</xref>
###xml 289 293 289 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Gekakis1">[28]</xref>
###xml 295 299 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Lowrey1">[29]</xref>
###xml 403 407 403 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Panda2">[30]</xref>
###xml 483 487 483 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
Recently multiple reports have discussed the relationship between cancer and circadian rhythm [24]-[26]. ARNTL is a core component of circadian rhythm transcriptional machinery [20], [27]. ARNTL binds to CLOCK and together they regulate expression of 1,000s of genes in a circadian timing [28], [29]. Genes regulated in a circadian fashion are involved in cell cycle, detoxification and other processes [30]. Therefore we decided to test if ARNTL is involved in the regulation of p21CIP1 expression in other cell systems.
###end p 38
###begin title 39
###xml 11 15 11 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 8 15 8 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>CIP1</sup></italic>
Reduced p21CIP1activation after DNA damage in HCT116 cells with ARNTL knockdown
###end title 39
###begin p 40
###xml 287 291 287 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 291 295 291 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Deng1">[31]</xref>
###xml 297 301 297 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Bunz1">[32]</xref>
###xml 356 360 356 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 353 360 353 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>CIP1</sup></italic>
###xml 610 614 610 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 779 783 779 783 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 890 894 886 890 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 950 959 946 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004798-g005">Figure 5a</xref>
###xml 1054 1058 1050 1054 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 1051 1058 1047 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>CIP1</sup></italic>
###xml 1132 1136 1128 1132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 7 12 <span type="species:ncbi:9606">human</span>
Normal human cells arrest either in G1 or S phase of the cell cycle after encountering DNA damage to repair the DNA, thereby preventing accumulation of mutations in the genome of daughter cells. The G1 phase cell cycle arrest is p53 dependent and mainly executed by the CDK inhibitor p21CIP1[31], [32] . To investigate if ARNTL is also required for the p21CIP1 activation after DNA damage, we infected U2OS osteosarcoma derived cells with different shRNAs targeting ARNTL. The cells were incubated to allow knockdown to take affect, after which cells were irradiated to inflict DNA damage and monitored for p21CIP1 activation. When we compared cells that were infected with a shRNA vector targeting p53 to cells infected with a control shRNA vector, we observed lower p53 and p21CIP1levels after gamma-radiation. In the cells infected with ARNTL knockdown vectors we also observed lower p21CIP1protein levels, but p53 protein levels were unaffected (Figure 5a). This observation suggests that ARNTL can modulate the activity of p53 towards its target p21CIP1. However, we cannot distinguish between a specific effect of ARNTL on p21CIP1and a more general effect of ARNTL on p53 transcriptional activity.
###end p 40
###begin title 41
###xml 19 23 19 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
ARNTL regulates p21CIP1 expression.
###end title 41
###begin p 42
###xml 52 56 52 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 323 327 319 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 658 664 654 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004798-g005">Fig 5b</xref>
###xml 750 754 746 750 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 783 786 779 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 848 852 844 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 1018 1022 1010 1014 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 1087 1096 1079 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004798-g005">figure 5c</xref>
a) Knockdown of ARNTL inhibits radiation induced p21CIP1 induction. U2OS cells were infected with the shRNA vectors as indicated. Cells were seeded and irradiated with 20 Gy of gamma-radiation. After o/n incubation cells were lysed and lysates were subjected to western blot using antibodies for p53, CDK4 (control) and p21CIP1. b) Knockdown of ARNTL can also rescue a p19-induced cell cycle arrest. U2OS cells were infected with the indicated shRNA vectors followed by a super-infection with p19ARF-RFP virus. Cells were seeded and incubated for three weeks. After three weeks the infected cells were fixed and stained. c) Knockdown of ARNTL in U2OS cells (Fig 5b) was quantified by QRT-PCR. d) ARNTL knockdown is not involved in p53 independent p21CIP1 induction. HCT116 wt and p53-/- cells were infected with knockdown vectors targeting p53, p21CIP1 and ARNTL. Cells were treated with 0.5 microM PXD101 for 16 hrs. Cells were then lysed and lysates were subjected to western analysis for p53, CDK4 (control) and p21CIP1. e) Quantification of p21 protein levels in the western blot in figure 5c using IMAGE J software.
###end p 42
###begin title 43
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 40 43 40 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
ARNTL knockdown also allows bypass a p19ARF induced growth arrest
###end title 43
###begin p 44
###xml 115 120 115 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 281 284 281 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 289 292 289 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 393 397 393 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Sherr1">[33]</xref>
###xml 416 419 416 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 470 474 470 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Pomerantz1">[34]</xref>
###xml 487 492 487 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 524 527 524 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 604 609 604 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 684 687 684 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 750 753 750 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 760 764 760 764 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 757 764 757 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>CIP1</sup></italic>
###xml 822 825 822 825 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 819 825 819 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19<sup>ARF</sup></italic>
###xml 827 836 827 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004798-g005">Figure 5b</xref>
###xml 852 857 852 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 918 921 918 921 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 941 950 941 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004798-g005">figure 5c</xref>
###xml 979 984 979 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 1049 1052 1049 1052 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 1070 1075 1070 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 68 72 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
As the BJtsLT cells are quite artificial due to the presence of the SV40 T viral oncogene, we also investigated if ARNTL knockdown could bypass a more physiological p53-induced cell cycle arrest. To address this, we used cells in which we can activate p53 by over-expression of p19ARF. p19ARF inhibits MDM2 function thereby leading to an increase of p53 protein and activation of target genes [33]. Activation of p19ARF leads to a stable p53-dependent cell cycle arrest [34]. To test if ARNTL knockdown can also rescue a p19ARF-induced cell cycle arrest, we infected U2OS cells with the shRNAs targeting ARNTL. After knockdown had taken effect the cells were super-infected with a p19ARF encoding retrovirus. We observed that cells with knockdown of p53 or p21CIP1 continue proliferation after the forced expression of p19ARF (Figure 5b), knockdown of ARNTL also allows cells to proliferate after p53 activation by p19ARF (for knockdown see figure 5c). This result suggests that ARNTL expression is required for the anti-proliferative response of 19ARF activation. When ARNTL levels are low, the cells escape this arrest.
###end p 44
###begin title 45
###xml 19 23 19 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 16 23 16 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>CIP1</sup></italic>
p53 independent p21CIP1activation does not require ARNTL
###end title 45
###begin p 46
###xml 77 81 77 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 74 81 74 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>CIP1</sup></italic>
###xml 153 157 153 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 324 328 324 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 321 328 321 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>CIP1</sup></italic>
###xml 380 384 380 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Qian1">[35]</xref>
###xml 385 389 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Gartel1">[38]</xref>
###xml 465 469 465 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 526 529 526 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 529 532 529 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 571 575 569 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Bunz1">[32]</xref>
###xml 598 601 596 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 659 663 657 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 677 689 675 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004798-g005">Fig 5d and e</xref>
###xml 702 705 700 703 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 752 756 750 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 749 756 747 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>CIP1</sup></italic>
###xml 773 777 771 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 865 870 863 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 921 925 919 923 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 1009 1013 1007 1011 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 1116 1120 1114 1118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cip1</sup>
###xml 1113 1120 1111 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>cip1</sup></italic>
###xml 1183 1187 1181 1185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 1180 1187 1178 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>CIP1</sup></italic>
The results described above suggest a role for ARNTL in the regulation of p21CIP1 expression by p53. However they do not rule out that ARNTL controls p21CIP1activation in a general fashion, independent of p53. To test this possibility we made use of small molecule HDAC inhibitors (HDACi). These HDACi cause induction of p21CIP1 in both a p53 dependent and p53 independent manner [35]-[38]. In order to study the effect of ARNTL on p53 independent activation of p21CIP1, we made use of a HCT116 p53 knockout cell-line (HCT116 p53-/-) and the HDACi PXD101 (Belinostat(R)) [32]. When these HCT116 p53-/- cells are treated with PXD-101, a strong induction of p21CIP1 is observed (Fig 5d and e). HCT116 p53-/- cells infected with a shRNA vector against p21CIP1 show reduced p21CIP1 protein levels after PXD-101 treatment. However, cells infected with a shRNA targeting ARNTL do not show any alteration in the induction of p21CIP1 protein levels following HDACi treatment. Thus the p53-independent induction of p21CIP1 by HDACi is not dependent on ARNTL. From this we conclude that ARNTL is not generally required for p21cip1 induction, but does affect the capacity of p53 to activate p21CIP1 expression.
###end p 46
###begin title 47
Discussion
###end title 47
###begin p 48
The screening of large-scale RNAi libraries has been used increasingly over the last years to identify the specific functions of genes in cellular pathways, networks and mechanisms. Here we describe the screening of a complex RNAi library to identify genes that were previously unknown to regulate a p53-dependent cell cycle arrest.
###end p 48
###begin p 49
###xml 557 561 533 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cip1</sup>
###xml 554 561 530 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>cip1</sup></italic>
###xml 642 647 618 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNIP1</italic>
###xml 649 654 625 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBCK1</italic>
###xml 659 664 635 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 52 57 <span type="species:ncbi:9606">human</span>
We have used the RNAi barcode technique to screen a human shRNA library containing approximately24,000 vectors targeting approximately8,000 genes. Using this approach, we were able to rapidly identify shRNAs that allow bypass of a p53 dependent cell cycle arrest. In total we confirmed that 32 out of the 37 genes that were identified by the barcode screen could indeed prevent cells from entering into a p53 dependent cell cycle arrest. However, only 5 of these 32 genes were targeted by two independent shRNAs. Two out of these five genes (TP53BP1 and p21cip1) are well-known to be involved in p53 signaling. However the other three genes (TNIP1, RBCK1 and ARNTL) were previously not known to be involved in the p53 pathway.
###end p 49
###begin p 50
###xml 84 88 84 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 195 199 195 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 431 435 431 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
The three newly identified genes all affect the induction of the p53 target gene p21CIP1 but no change in p53 protein stability is observed after ARNTL, TNIP1 or RBCK1 knockdown. Importantly, p21CIP1 knockdown alone is sufficient to rescue cells from the p53 induced cell cycle arrest. This observation indicates that the rescue of the p53 induced cell cycle arrest by ARNTL, RBCK1 or TNIP1 knockdown is the result of a lack of p21CIP1 induction by p53.
###end p 50
###begin p 51
###xml 298 302 294 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Heyninck1">[22]</xref>
###xml 304 308 300 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Heyninck2">[39]</xref>
###xml 607 611 599 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Yamanaka1">[21]</xref>
###xml 613 617 605 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Bayle1">[40]</xref>
###xml 618 622 610 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Tian1">[42]</xref>
###xml 712 716 704 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Tatematsu1">[43]</xref>
###xml 1060 1065 1052 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 1129 1133 1121 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Bunger1">[20]</xref>
###xml 1152 1157 1144 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 1207 1211 1199 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Kondratov1">[44]</xref>
###xml 1401 1405 1393 1397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Matsuo1">[45]</xref>
###xml 1655 1659 1647 1651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Fu1">[24]</xref>
###xml 1660 1664 1652 1656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Gery1">[26]</xref>
###xml 1685 1693 1677 1685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Period 1</italic>
###xml 1698 1699 1690 1691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 1025 1030 <span type="species:ncbi:10090">mouse</span>
###xml 1032 1036 <span type="species:ncbi:10090">Mice</span>
###xml 1167 1172 <span type="species:ncbi:10090">mouse</span>
###xml 1508 1513 <span type="species:ncbi:10090">mouse</span>
###xml 1519 1524 <span type="species:ncbi:10090">mouse</span>
The activity of p53 has been mainly attributed to its role as transcription factor with tumor suppressive capacities. Therefore, we assessed if any of the genes identified in our screen had been linked to transcription before. TNIP1 was originally identified as an inhibitor of NF-kappaB signaling [22], [39]. Although it was shown that TNIP1 over-expression inhibits the transcriptional activity of the NF-kappaB heterodimer it is believed that this is an indirect effect through an currently unknown mechanism. The ubiquitin E3 ligase RBCK1 has been reported to regulate and ubiquitinate several proteins [21], [40]-[42]. Although experiments have been performed that suggest a role for RBCK1 in transcription [43] a clear role for RBCK1 in regulating transcription has not been reported up till now. This picture is different for ARNTL which is known to be the central transcription factor in regulating circadian rhythm. The critical role of ARTNL in circadian rhythm was demonstrated by the construction of the knockout mouse. Mice that are deficient for ARNTL are unable to maintain a circadian rhythm in constant darkness [20]. In addition, the ARNTL knockout mouse also suffers from premature aging [44]. In recent years, many other processes have been shown to be regulated in a circadian fashion. Most importantly it was shown that the mammalian cell cycle is controlled by circadian rhythm [45]. The possible involvement of circadian rhythm in cancer results from studies of the Period 2 knockout mouse.This mouse is prone to develop tumors after radiation. Later it was shown that also the Period 1 protein can regulate cell cycle checkpoints [24]-[26]. Interestingly both Period 1 and 2 are bona-fide transcriptional targets of ARNTL.
###end p 51
###begin p 52
###xml 87 91 87 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Gekakis1">[28]</xref>
###xml 149 157 149 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Period 1</italic>
###xml 159 160 159 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 165 166 165 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</italic>
###xml 171 184 171 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cryptochromes</italic>
###xml 186 195 186 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cry 1 &amp; 2</italic>
###xml 197 201 197 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Shearman1">[46]</xref>
###xml 263 267 263 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Young1">[47]</xref>
For the induction of target genes ARNTL must form a heterodimer with the CLOCK protein [28]. Target genes of the CLOCK/ARNTL heterodimer include the Period 1, 2 and 3 and Cryptochromes (Cry 1 & 2) [46]. The increased abundance of Period and Cryptochrome proteins [47] induces a negative feedback loop that ultimately shuts down transcription by the CLOCK/ARTNL heterodimer. When the concentration of Period and Cryptochrome decreases due to proteasomal degradation the CLOCK/ARNTL complex can initiate another round of transcription thereby completing a cycle of circadian rhythm.
###end p 52
###begin p 53
###xml 74 78 74 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 71 78 71 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>CIP1</sup></italic>
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-GrechezCassiau1">[48]</xref>
###xml 149 154 149 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 209 213 209 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 206 213 206 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>CIP1</sup></italic>
###xml 318 322 318 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 315 322 315 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>CIP1</sup></italic>
###xml 370 374 370 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 389 394 389 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 409 413 409 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-GrechezCassiau1">[48]</xref>
###xml 432 437 432 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 485 489 485 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 482 489 482 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>CIP1</sup></italic>
###xml 564 568 564 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 672 680 672 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 688 695 688 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 168 173 <span type="species:ncbi:9606">human</span>
###xml 404 408 <span type="species:ncbi:10090">mice</span>
###xml 581 585 <span type="species:ncbi:10090">mice</span>
###xml 589 592 <span type="species:ncbi:9606">man</span>
###xml 847 852 <span type="species:ncbi:9606">human</span>
Another transcriptional target of the CLOCK/ARNTL is the CDK inhibitor p21CIP1 which is also regulated in a circadian manner [48]. We show here that ARNTL knockdown in human cells can abrogate induction of p21CIP1 after p53 activation and overrides a p53-dependent cell cycle arrest. The effect on the induction of p21CIP1 is in contrast with previous reports on the p21CIP1 regulation in ARNTL knockout mice [48]. In these animals ARNTL is required for the circadian expression of p21CIP1. This discrepancy might be explained by differential regulation of the p21CIP1 promoter in mice or man. In particular, this difference may arise from stress signals differences from in vitro versus in vivo conditions. Nevertheless, our data clearly indicate that there is a link between the regulation of circadian rhythm and the control of p53 activity in human cells.
###end p 53
###begin title 54
Conclusions
###end title 54
###begin p 55
###xml 220 224 220 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 217 224 217 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>CIP1</sup></italic>
###xml 321 325 321 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 318 325 318 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>CIP1</sup></italic>
###xml 398 401 398 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 490 495 490 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 43 48 <span type="species:ncbi:9606">human</span>
By screening a large scale RNAi library in human cells we have identified three novel genes that can regulate p53 function. Loss of expression for each of three genes results in a decreased ability of p53 to activate p21CIP1 expression. Importantly, we showed that ARNTL is required for the p53-dependent induction of p21CIP1 in two additional cell types using different ways to activate p53: a p19ARF-induced cell cycle arrest and a DNA damage mediated cell cycle arrest. We conclude that ARNTL suppression affects the ability of p53 to induce a cell cycle arrest upon cellular stress signals such as DNA damage.
###end p 55
###begin title 56
Materials and Methods
###end title 56
###begin title 57
Cell lines & culture conditions
###end title 57
###begin p 58
###xml 177 178 171 172 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 337 338 325 326 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
BJtsLT cells were cultured in medium that consisted of DMEM 75% / M199 25% supplemented with 10% FCS, Penicillin and Glutamine. BJtsLT cells were cultured at 32degreesC in 5% CO2. U2OS and Phoenix cells were cultured in DMEM supplemented with 10% FCS, Penicillin and Glutamine. U2OS and Phoenix cells were cultured at 37degreesC in 5% CO2.
###end p 58
###begin title 59
Plasmids and library
###end title 59
###begin p 60
###xml 172 176 172 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Berns1">[11]</xref>
###xml 235 239 235 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004798-Berns1">[11]</xref>
###xml 300 305 <span type="species:ncbi:9606">human</span>
Expression plasmid for ARNTL was generated by PCR from a cDNA library and subsequent cloning the PCR product into pCR3-Flag. The P19-RFP construct was described previously [11]. The construction of the library was described previously [11]. Briefly, the NKI shRNA library was designed to target 7914 human genes, using three shRNA vectors for every targeted gene, cumulating in a total of 23,742 shRNA vectors. The shRNAs are cloned into a retro-viral vector to enable infection of target cells.
###end p 60
###begin title 61
Retroviral infection
###end title 61
###begin p 62
Phoenix cells were transfected using calcium phosphate method. Viral supernatant was cleared through a 0.45 microM filter. Cells were infected with the viral supernatant in presence of polybrene (8 microg/ml). The infection was repeated twice.
###end p 62
###begin title 63
shRNA barcode screen
###end title 63
###begin p 64
###xml 317 318 317 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 910 911 886 887 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
To screen the NKI shRNA library we reasoned that we would need 100 fold coverage of the library to get a good representation of all 23,742 shRNA vectors present in the library. BJtsLT cells were infected with the NKI shRNA library. Two days after infection cells were plated at 150,000 cells/15 cm dish. In total 2x106 cells were shifted to 39degreesC, equal number of cells were kept at 32degreesC. Cells at 32degreesC were harvested after 5 days. Cells at 39degreesC were harvested at 21 days after shift. From both populations gDNA was isolated using DNAzol (Invitrogen). The shRNA cassettes were amplified by PCR. The PCR product was used for in vitro RNA synthesis. RNA was labeled with Cy3 or Cy5 (Kreatech) and hybridized on a microarray. Quantification of the resulting fluorescent images was performed with Imagene 5.6 (BioDiscovery), local background was subtracted, and the data were normalized and 2log transformed. Additional information on barcode screens can be found at .
###end p 64
###begin title 65
Colony formation assay
###end title 65
###begin p 66
Cells were infected with retroviral supernatant. Two days after infection the cells were seeded at 50,000/10 cm dish and shifted to 39degreesC. Cells were cultured at 39degreesC for approx 21 days. When colonies appeared cells were fixed in MeOH/HAc (3:1) and subsequently stained (50% MeOH/10% HAc/0.1% Coomassie).
###end p 66
###begin title 67
Western blotting
###end title 67
###begin p 68
###xml 349 353 349 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
Cell lysates were separated using 10% SDS-PAAGE. Proteins were transferred to PVDF membrane and incubated with primary antibody as indicated. Primary antibodies were detected using a secondary HRP-conjugated antibody. Antibodies used for these studies: Flag (M2; Sigma), TNIP1 (1A11E3; Zymed), CDK4 (C-22; Santa Cruz), p53 (DO-1; Santa Cruz) and p21CIP1 (C-19; Santa Cruz).
###end p 68
###begin title 69
QRT-PCR
###end title 69
###begin p 70
Total RNA was isolated using TRIzol (Invitrogen). From the total RNA cDNA was generated using Superscript II (Invitrogen) using random primers (Invitrogen). cDNA was diluted and QRT reaction was performed using Taqman probes (Applied Biosystems). All QRT reactions were run in parallel for GAPDH to control of for input cDNA. The QRT reactions were run at a AB7500 Fast Real Time PCR system (Applied Biosystems). Results shown are a representative of three independent experiments.
###end p 70
###begin title 71
###xml 3 7 3 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
p21CIP1 induction by gamma-radiation and PXD101
###end title 71
###begin p 72
###xml 11 15 11 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 215 219 211 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
For the p21CIP1 induction by radiation 50,000 cells were seeded per 6-well. HCT116 p53-/- cells were irradiated with 20 Gy gamma-radiation from a Cs-137 source. Cells were incubated for 16 hrs and lysed. For the p21CIP1 induction by PXD101 50,000 cells were seeded/6-well and treated with 0.5 microM PXD101 for 16 hrs after which the cells were lysed and protein lysates were subjected to western analysis.
###end p 72
###begin p 73
We thank K Berns and EM Heijmans for the BJtsLT cells. In addition, we thank all members of the Beijersbergen and Bernards labs for helpful discussions.
###end p 73
###begin title 74
References
###end title 74
###begin article-title 75
p53 in health and disease.
###end article-title 75
###begin article-title 76
Regulating the p53 pathway: in vitro hypotheses, in vivo veritas.
###end article-title 76
###begin article-title 77
Regulation of p53 activity through lysine methylation.
###end article-title 77
###begin article-title 78
p53 ubiquitination: Mdm2 and beyond.
###end article-title 78
###begin article-title 79
Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation.
###end article-title 79
###begin article-title 80
Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.
###end article-title 80
###begin article-title 81
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.
###end article-title 81
###begin article-title 82
###xml 27 32 <span type="species:ncbi:9606">human</span>
Transcriptional control of human p53-regulated genes.
###end article-title 82
###begin article-title 83
###xml 61 66 <span type="species:ncbi:9606">human</span>
Amplification of a gene encoding a p53-associated protein in human sarcomas.
###end article-title 83
###begin article-title 84
###xml 29 34 <span type="species:ncbi:9606">human</span>
A large-scale RNAi screen in human cells identifies new components of the p53 pathway.
###end article-title 84
###begin article-title 85
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.
###end article-title 85
###begin article-title 86
An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors.
###end article-title 86
###begin article-title 87
shRNA libraries and their use in cancer genetics.
###end article-title 87
###begin article-title 88
A loss-of-function RNA interference screen for molecular targets in cancer.
###end article-title 88
###begin article-title 89
###xml 29 34 <span type="species:ncbi:9606">human</span>
Profiling essential genes in human mammary cells by multiplex RNAi screening.
###end article-title 89
###begin article-title 90
Cancer proliferation gene discovery through functional genomics.
###end article-title 90
###begin article-title 91
3' UTR seed matches, but not overall identity, are associated with RNAi off-targets.
###end article-title 91
###begin article-title 92
Minimizing the risk of reporting false positives in large-scale RNAi screens.
###end article-title 92
###begin article-title 93
Mop3 is an essential component of the master circadian pacemaker in mammals.
###end article-title 93
###begin article-title 94
Identification of the ubiquitin-protein ligase that recognizes oxidized IRP2.
###end article-title 94
###begin article-title 95
The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN.
###end article-title 95
###begin article-title 96
WAF1, a potential mediator of p53 tumor suppression.
###end article-title 96
###begin article-title 97
The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo.
###end article-title 97
###begin article-title 98
The circadian clock: pacemaker and tumour suppressor.
###end article-title 98
###begin article-title 99
###xml 89 94 <span type="species:ncbi:9606">human</span>
The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells.
###end article-title 99
###begin article-title 100
###xml 32 37 <span type="species:ncbi:9606">human</span>
Circadian rhythms from flies to human.
###end article-title 100
###begin article-title 101
Role of the CLOCK protein in the mammalian circadian mechanism.
###end article-title 101
###begin article-title 102
Mammalian circadian biology: elucidating genome-wide levels of temporal organization.
###end article-title 102
###begin article-title 103
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
Coordinated transcription of key pathways in the mouse by the circadian clock.
###end article-title 103
###begin article-title 104
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control.
###end article-title 104
###begin article-title 105
Requirement for p53 and p21 to sustain G2 arrest after DNA damage.
###end article-title 105
###begin article-title 106
Divorcing ARF and p53: an unsettled case.
###end article-title 106
###begin article-title 107
The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.
###end article-title 107
###begin article-title 108
Activity of the histone deacetylase inhibitor belinostat (PXD101) in preclinical models of prostate cancer.
###end article-title 108
###begin article-title 109
Histone deacetylase inhibitors: signalling towards p21cip1/waf1.
###end article-title 109
###begin article-title 110
The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene.
###end article-title 110
###begin article-title 111
Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3.
###end article-title 111
###begin article-title 112
Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1.
###end article-title 112
###begin article-title 113
The E3 ubiquitin ligase HOIL-1 induces the polyubiquitination and degradation of SOCS6 associated proteins.
###end article-title 113
###begin article-title 114
A ubiquitin ligase complex assembles linear polyubiquitin chains.
###end article-title 114
###begin article-title 115
RBCK1 negatively regulates tumor necrosis factor- and interleukin-1-triggered NF-kappaB activation by targeting TAB2/3 for degradation.
###end article-title 115
###begin article-title 116
Nuclear-cytoplasmic shuttling of a RING-IBR protein RBCK1 and its functional interaction with nuclear body proteins.
###end article-title 116
###begin article-title 117
###xml 43 47 <span type="species:ncbi:10090">mice</span>
Early aging and age-related pathologies in mice deficient in BMAL1, the core componentof the circadian clock.
###end article-title 117
###begin article-title 118
Control mechanism of the circadian clock for timing of cell division in vivo.
###end article-title 118
###begin article-title 119
Interacting molecular loops in the mammalian circadian clock.
###end article-title 119
###begin article-title 120
Time zones: a comparative genetics of circadian clocks.
###end article-title 120
###begin article-title 121
The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation.
###end article-title 121
###begin p 122
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 122
###begin p 123
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This research was funded by the Dutch Cancer Society (KWF) and by the EU 6th framework program TRANSFOG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 123

